Bubonic plague future or investigational therapies

Jump to navigation Jump to search

Bubonic plague Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bubonic plague from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bubonic plague future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bubonic plague future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bubonic plague future or investigational therapies

CDC on Bubonic plague future or investigational therapies

Bubonic plague future or investigational therapies in the news

Blogs on Bubonic plague future or investigational therapies

Directions to Hospitals Treating Bubonic plague

Risk calculators and risk factors for Bubonic plague future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.

Overview

The main investigational technique being looked into is that of a vaccine to stop any possible plague outbreaks. Currently, there is not an available vaccine against the plague, particularly the pneumonic version. This all may be changing because there has been research conducted giving promising results for a vaccine against the pneumonic plague.

Pneumonic plague vaccine

Before recently, there were attempts to make a possible vaccine from a live form of the virus. Unfortunately, the live Y.Pestis strain is genetically unstable, which does not make it suitable for a vaccination.[1] Instead of using the unstable Y.Pestis a research group decided to create a strain of the Y. pseudotuberculosis gene which shares more than 95% of its genetic identity with Y.Pestis. [1]. This gene is far more stable and it has shown promising results as a an oral vaccine for the plague. This vaccine has become a good candidate for helping stop the spread and mortality of pneumonic plague.[1]

References

  1. 1.0 1.1 1.2 Derbise A, Cerdà Marín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE (2012). "An Encapsulated Yersinia pseudotuberculosis Is a Highly Efficient Vaccine against Pneumonic Plague". PLoS Neglected Tropical Diseases. 6 (2): e1528. doi:10.1371/journal.pntd.0001528. PMC 3279354. PMID 22348169. Retrieved 2012-03-02. Unknown parameter |month= ignored (help)